1. |
|
|
2. |
|
|
3. |
- Abu-Elyazeed, R R, et al.
(författare)
-
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age : results from a randomised, controlled, double-blind trial
- 2013
-
Ingår i: Vaccine. - : Elsevier BV. - 0264-410X .- 1873-2518. ; 31:51, s. 6136-6143
-
Tidskriftsartikel (refereegranskat)abstract
- OBJECTIVE: The investigational AS04-adjuvanted herpes simplex virus type 2 (HSV-2) glycoprotein D (gD2) subunit prophylactic vaccine ('HSV vaccine'; GlaxoSmithKline Vaccines) has been shown to be well tolerated in adults, but limited data exist for pre-teen and adolescent girls, a likely target population. The primary objective of this study was to compare the occurrence of serious adverse events (SAEs) over 12 months between HSV vaccine recipients and saline recipients (placebo control group) in pre-teen and adolescent girls. The immunogenicity of the HSV vaccine was also assessed.METHODS: Healthy girls aged 10-17 years, stratified by age (10-15 years; 16-17 years), were randomised 2:1:1 to receive the HSV vaccine, a hepatitis A vaccine (Havrix™; HAV control) or placebo (saline) according to a 0-, 1-, 6-month schedule. Participants and study personnel not involved in the preparation or administration of vaccines were blinded to treatment. Safety and immunogenicity analyses were performed overall and by age (10-15 years; 16-17 years) and HSV serostatus.RESULTS: No statistically significant difference in the percentage of subjects with SAEs was observed between the HSV and saline group, or between the HSV and pooled control (HAV and saline) groups. The HSV vaccine was well tolerated, although a higher incidence of solicited local symptoms was observed in the HSV group than in the control group. Neither age nor HSV serostatus at the time of study entry had an impact on the safety profile of this vaccine. The HSV vaccine was immunogenic regardless of pre-vaccination HSV serostatus. Higher anti-gD geometric mean concentrations were observed in HSV-1 seropositive participants than in HSV-1 seronegative participants.CONCLUSION: The HSV vaccine had an acceptable safety profile, and was well tolerated and immunogenic when administered to girls aged 10-17 years regardless of age or HSV pre-vaccination serostatus.
|
|
4. |
|
|
5. |
- Au, A. E., et al.
(författare)
-
Altered B-lymphopoiesis in mice with deregulated thrombopoietin signaling
- 2017
-
Ingår i: Scientific Reports. - : Springer Science and Business Media LLC. - 2045-2322. ; 7:1
-
Tidskriftsartikel (refereegranskat)abstract
- Thrombopoietin (TPO) is the master cytokine regulator of megakaryopoiesis. In addition to regulation of megakaryocyte and platelet number, TPO is important for maintaining proper hematopoietic stem cell (HSC) function. It was previously shown that a number of lymphoid genes were upregulated in HSCs from Tpo(-/-)mice. We investigated if absent or enhanced TPO signaling would influence normal B-lymphopoiesis. Absent TPO signaling in Mpl(-/-)mice led to enrichment of a common lymphoid progenitor (CLP) signature in multipotential lineage-negative Sca-1(+)c-Kit(+) (LSK) cells and an increase in CLP formation. Moreover, Mpl(-/-)mice exhibited increased numbers of PreB2 and immature B-cells in bone marrow and spleen, with an increased proportion of B-lymphoid cells in the G1 phase of the cell cycle. Conversely, elevated TPO signaling in Tpo(Tg) mice was associated with reduced B-lymphopoiesis. Although at steady state, peripheral blood lymphocyte counts were normal in both models, Mpl(-/-)E mu-myc mice showed an enhanced preneoplastic phase with increased numbers of splenic PreB2 and immature B-cells, a reduced quiescent fraction, and augmented blood lymphocyte counts. Thus, although Mpl is not expressed on lymphoid cells, TPO signaling may indirectly influence B-lymphopoiesis and the preneoplastic state in Myc-driven B-cell lymphomagenesis by lineage priming in multipotential progenitor cells.
|
|
6. |
|
|
7. |
|
|
8. |
|
|
9. |
- Ebenhag, Sven-Christian, 1976, et al.
(författare)
-
Two-way coherent frequency transfer in a commercial DWDM communication network in Sweden
- 2015
-
Ingår i: 2015 Joint Conference of the IEEE International Frequency Control Symposium and the European Frequency and Time Forum, FCS 2015 - Proceedings. - 1075-6787. - 9781479988662 ; , s. 276-279
-
Konferensbidrag (refereegranskat)abstract
- An experimental fiber link is being established between SP Technical Research Institute of Sweden in Boras and Chalmers University of Gothenburg in Sweden. The one way fiber length is about 60 km and implemented in SUNET (Swedish University Network). The aim of the project is to evaluate the signal quality when sending a stable optical frequency utilizing a wavelength in a DWDM (Dense Wavelength Division Multiplexing) system fiber pair. The experiment uses a channel in the DWDM with the wavelength of 1542.14 nm. This wavelength is within the C band and is therefore compatible with common Erbium doped amplifiers in this network. Another aim of the system is to be ultra-stable which corresponds to a stability of 1×10-13 for τ = 1 s as well as providing the ability to distribute monitored ultra-stable frequency with a future traceability to UTC (SP) (National realization of Universal Time Coordinated within Sweden) to multiple users within the network. Measurements of an optical frequency transfer using a fiber-link based on unidirectional light signals in parallel fibers have shown promising results in a free-running setup and in a lab environment. The fractional frequency stability, analyzed as the Overlapping Allan deviation, is approximately 3×10-13 at τ = 10 s and almost 1×10-14 at 105 s.
|
|
10. |
|
|